Assess the Safety and Effectiveness of Once Daily PMR Compared to Twice Daily Pletaal® in Patients With Intermittent Claudication

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The study is designed to compare the efficacy and safety of once daily PMR treatment with twice daily Pletaal® treatment in patients with intermittent claudication caused by peripheral arterial disease and are currently treated with cilostazol of any strength and any dosing frequency.
Epistemonikos ID: a81d7e904acd9a2180d51c11d97cc067dc426129
First added on: Mar 27, 2025